We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus. Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days. Seventeen infants were treated with placebo, and 16 with ribavirin. By the end of treatment, infants receiving ribavirin had significantly greater improvement in their overall score for severity of illness, in lower-respiratory-tract signs, and in arterial oxygen saturation. Viral shedding was also diminished in the treated groups as compared with the placebo group. No side effects or toxicity were associated with the aerosol therapy. Isolates of respiratory syncytial virus obtained from the infants over the course of therapy showed no change in sensitivity to ribavirin.
This article has been cited by other articles:
Subcommittee on Diagnosis and Management of Bronch,
(2006). Diagnosis and Management of Bronchiolitis. Pediatrics
118: 1774-1793
[Abstract][Full Text]
Liuzzi, M., Mason, S. W., Cartier, M., Lawetz, C., McCollum, R. S., Dansereau, N., Bolger, G., Lapeyre, N., Gaudette, Y., Lagace, L., Massariol, M.-J., Do, F., Whitehead, P., Lamarre, L., Scouten, E., Bordeleau, J., Landry, S., Rancourt, J., Fazal, G., Simoneau, B.
(2005). Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA Polymerase. J. Virol.
79: 13105-13115
[Abstract][Full Text]
Mason, S. W., Lawetz, C., Gaudette, Y., Do, F., Scouten, E., Lagace, L., Simoneau, B., Liuzzi, M.
(2004). Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor. Nucleic Acids Res
32: 4758-4767
[Abstract][Full Text]
Easton, A. J., Domachowske, J. B., Rosenberg, H. F.
(2004). Animal Pneumoviruses: Molecular Genetics and Pathogenesis. Clin. Microbiol. Rev.
17: 390-412
[Abstract][Full Text]
King, V. J., Viswanathan, M., Bordley, W. C., Jackman, A. M., Sutton, S. F., Lohr, K. N., Carey, T. S.
(2004). Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review. Arch Pediatr Adolesc Med
158: 127-137
[Abstract][Full Text]
Bonville, C. A., Easton, A. J., Rosenberg, H. F., Domachowske, J. B.
(2002). Altered Pathogenesis of Severe Pneumovirus Infection in Response to Combined Antiviral and Specific Immunomodulatory Agents. J. Virol.
77: 1237-1244
[Abstract][Full Text]
Tam, R. C., Ramasamy, K., Bard, J., Pai, B., Lim, C., Averett, D. R.
(2000). The Ribavirin Analog ICN 17261 Demonstrates Reduced Toxicity and Antiviral Effects with Retention of both Immunomodulatory Activity and Reduction of Hepatitis-Induced Serum Alanine Aminotransferase Levels. Antimicrob. Agents Chemother.
44: 1276-1283
[Abstract][Full Text]
Tam, R. C., Lim, C., Bard, J., Pai, B.
(1999). Contact Hypersensitivity Responses Following Ribavirin Treatment In Vivo Are Influenced by Type 1 Cytokine Polarization, Regulation of IL-10 Expression, and Costimulatory Signaling. J. Immunol.
163: 3709-3717
[Abstract][Full Text]
Jordan, I., Briese, T., Averett, D. R., Lipkin, W. I.
(1999). Inhibition of Borna Disease Virus Replication by Ribavirin. J. Virol.
73: 7903-7906
[Abstract][Full Text]
GUERGUERIAN, A.-M., GAUTHIER, M., LEBEL, M. H., FARRELL, C. A., LACROIX, J.
(1999). Ribavirin in Ventilated Respiratory Syncytial Virus Bronchiolitis . A Randomized, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med.
160: 829-834
[Abstract][Full Text]
Balfour, H. H.
(1999). Antiviral Drugs. NEJM
340: 1255-1268
[Full Text]
Sudo, K., Watanabe, W., Konno, K., Sato, R., Kajiyashiki, T., Shigeta, S., Yokota, T.
(1999). Efficacy of RD3-0028 Aerosol Treatment against Respiratory Syncytial Virus Infection in Immunosuppressed Mice. Antimicrob. Agents Chemother.
43: 752-757
[Abstract][Full Text]
Domachowske, J. B., Rosenberg, H. F.
(1999). Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment. Clin. Microbiol. Rev.
12: 298-309
[Abstract][Full Text]
MOLER, F. W., OHMIT, S. E.
(1999). Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization. Am. J. Respir. Crit. Care Med.
159: 1234-1240
[Abstract][Full Text]
Fox, G. F, Everard, M. L, Marsh, M. J, Milner, A. D
(1999). Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch. Dis. Child.
80: 343-347
[Abstract][Full Text]
Rodriguez, W. J., Gruber, W. C., Groothuis, J. R., Simoes, E. A. F., Rosas, A. J., Lepow, M., , A. K., Hemming, V., the RSV-IGIV Study Group,
(1997). Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children. Pediatrics
100: 937-942
[Abstract][Full Text]
Law, B. J., Wang, E. E. L., MacDonald, N., McDonald, J., Dobson, S., Boucher, F., Langley, J., Robinson, J., Mitchell, I., Stephens, D.
(1997). Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database. Pediatrics
99: e7-e7
[Abstract][Full Text]
Rodriguez, W. J., Gruber, W. C., Welliver, R. C., Groothuis, J. R., Simoes, E. A. F., Meissner, H. C., Hemming, V. G., Hall, C. B., Lepow, M. L., Rosas, A. J., Robertsen, C., Kramer, A. A.
(1997). Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections. Pediatrics
99: 454-461
[Abstract][Full Text]
Marks, M. I.
(1992). Respiratory Syncytial Virus Infections. CLIN PEDIATR
31: 688-691
Friedman, A. D., Naqvi, S. H., Arens, M. Q., Eyler, M. A.
(1986). Value of Rapid Diagnosis of Respiratory Syncytial Virus Infection on Management of Small Infants. CLIN PEDIATR
25: 404-406
[Abstract]
Padman, R., Bye, M. R., Schidlow, D. V., Zaeri, N.
(1985). Severe RSV Bronchiolitis in an Immunocompromised Child. CLIN PEDIATR
24: 719-721
[Abstract]
Dolin, R
(1985). Antiviral chemotherapy and chemoprophylaxis. Science
227: 1296-1303
[Abstract]